Pharmaceutical - Women's Health, Licensing

Filter

Current filters:

Women's HealthLicensing

Popular Filters

Dilafor partners with Lee’s Pharmaceutical for tafoxiparin

24-02-2014

Sweden-based Dilafor AB, a Karolinska Development portfolio company, and Lee’s Pharmaceutical Holdings,…

Asia-PacificChinaDilafor ABKarolinska DevelopmentLee's PharmaceuticalLicensingPharmaceuticalReproductivetafoxiparinWomen's Health

Advaxis out-licenses ADXS-HPV to Biocon for emerging markets

Advaxis out-licenses ADXS-HPV to Biocon for emerging markets

23-01-2014

Indian biotech firm Biocon has entered into an exclusive licensing agreement for US cancer drug developer…

AdvaxisADXS-HPVAsia-PacificBioconIndiaLicensingOncologyPharmaceuticalWomen's Health

Retrophin to acquire Kyalin Biosciences; in-licenses Syntocinon

13-12-2013

In a second takeover bid within a matter of months, USA-based Retrophin announced that it will acquire…

Kyalin BiosciencesLicensingMergers & AcquisitionsNeurologicalNorth AmericaNovartisPharmaceuticalRetrophinSyntocinonWomen's Health

Ablynx and Eddingpharm sign deal to target Chinese osteoporosis market

Ablynx and Eddingpharm sign deal to target Chinese osteoporosis market

18-10-2013

Ablynx has granted an exclusive license to Eddingpharm to develop and commercialize its anti-RANKL Nanobody,…

AblynxAsia-PacificEddingpharmLicensingPharmaceuticalWomen's Health

Phebra gains right to market Syntometrine in Australia

Phebra gains right to market Syntometrine in Australia

27-09-2013

Phebra has signed an exclusive commercial agreement with UK-based pharmaceutical firm Alliance Pharma…

Alliance PharmaAsia-PacificLicensingPharmaceuticalSyntometrineWomen's Health

Pharmaceutical patent sale of first-in-class compounds to treat women's health needs

31-08-2013

IP Shakti, an early-stage seed fund for biomedical and life science innovations and the exclusive broker…

BezielleIP ShaktiLicensingMenerbaPatentsPharmaceuticalSealaWomen's Health

ObsEva gets funding and makes deal with Merck Serono

30-08-2013

Geneva, Switzerland-based ObsEva says that it has closed a 32 million Swiss franc ($34.8 million) -A…

FinancialLicensingMerck KGaAMerck SeronoObsEvaPharmaceuticalWomen's Health

Actavis gains global rights for antifungal agent albaconazole

06-08-2013

US generic drugs major Actavis (NYSE: ACT),which also has strong interests in women's health products,…

ActavisalbaconazoleGlobalLicensingPalau PharmaPharmaceuticalWomen's Health

BMG Pharma and Julphar in women's health licensing deal

25-07-2013

Italian specialty drugmaker BMG Pharma and United Arab Emirates-based Julphar - Gulf Pharmaceutical Industries…

BMG GinoxilBMG PharmaJulpharLicensingPharmaceuticalRest of the WorldWomen's Health

Ligand enters global license deal for women's health product

23-07-2013

Ligand Pharmaceuticals (Nasdaq: LGND) announces the signing of a global license agreement with recently-formed…

Azure BiotechBiotechnologyGloballasofoxifeneLicensingLigand PharmaceuticalsPfizerPharmaceuticalWomen's Health

Sinclair IS in Flammacerium deal with Hikma; sells Fazol G to Majorelle

19-03-2013

UK specialty pharma firm Sinclair IS Pharma (AIM: SPH.L) and Jordon-headquartered Hikma Pharmaceuticals…

Antibiotics and Infectious diseasesFazol GHikma PharmaceuticalsLaboratoires MajorelleLicensingPharmaceuticalSinclair IS PharmaWomen's Health

Bayer inks up to 592 million-euro endometriosis deal with Evotec

02-10-2012

Drug major Bayer (BAYN: DE) and fellow German company Evotec (EVT: TecDAX) have entered into a five-year,…

BayerEvotecLicensingPharmaceuticalWomen's Health

BioSante Pill-Plus improves sexual desire, arousal

20-03-2012

US drug developer BioSante Pharmaceuticals (Nasdaq: BPAX) says that data from studies of the Pill-Plus…

BioSante PharmaceuticalsLicensingPantarhei BiosciencePharmaceuticalPill-PlusReproductiveResearchWomen's Health

Columbia Labs hands over NDA to Watson

13-02-2012

Columbia Laboratories (Nasdaq: CBRX) has transferred the New Drug Application for progesterone vaginal…

Columbia LaboratoriesCrinoneLicensingNorth AmericaPharmaceuticalRegulationReproductiveWatson PharmaceuticalsWomen's Health

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top